Structure-sparing resection for the management of cervical chordomas: a retrospective institutional series

医学 脊索瘤 外科 斜坡 回顾性队列研究 放射治疗 颅骨
作者
Adam S. Levy,Aria Jamshidi,Meredith C. Costello,Allan D. Levi
出处
期刊:Neurosurgical Focus [American Association of Neurological Surgeons]
卷期号:56 (5): E6-E6
标识
DOI:10.3171/2024.2.focus23710
摘要

OBJECTIVE Chordomas are a rare and relatively slow-growing malignancy of notochordal origin with a nearly 50% recurrence rate. Chordomas of the cervical spine are particularly challenging tumors given surrounding vital anatomical structures. Although standard in other areas of the spine, en bloc resection of cervical chordomas is exceedingly difficult and carries the risk of significant postoperative morbidity. Here, the authors present their institutional experience with 13 patients treated with a structure-sparing radical resection and adjuvant radiation for cervical chordomas. METHODS Records of the standing senior author and institutional database of spinal surgeries were retrospectively reviewed for surgically managed cervical and high thoracic chordomas between 1997 and 2022. Chordomas whose epicenter was cervical but touched the clivus or had extension to the thoracic spine were included in this series. Clinical and operative data were gathered and analyzed for the index surgery and any revisions needed. Outcome metrics such as recurrence rates, complication rates, functional status, progression-free interval (PFI) and overall survival (OS) were evaluated. RESULTS The median patient age at diagnosis was 57 (range 32–80) years. The median modified Rankin Scale (mRS) score at the time of presentation was 1 (range 0–4). Approximately 40% of tumors were located in the upper cervical spine (occiput–C2). The median time from diagnosis to surgery was 74.5 (range 10–483) days. Gross-total resection was achieved in just under 40% of patients. All patients received adjuvant radiotherapy. The mean duration of follow-up was 4.09 years, with a mean PFI of 3.80 (range 1.16–13.1) years. Five patients experienced recurrence (38.5%). The mean OS was 3.44 years. Three patients died during the follow-up period; 2 due to disease progression and 1 died in the immediate postoperative period. One patient was lost to follow-up. A significant positive relationship was identified between high cervical tumor location and disease recurrence (p = 0.021). CONCLUSIONS While en bloc resection is appropriate and feasible for tumors in the sacral spine, the cervical region poses a significant technical challenge and is associated with increased postoperative morbidity. Radical resection may allow for achievement of negative operative margins and, along with sparing postoperative morbidity following resection of cervical chordomas, maintaining a similar rate of recurrence when compared with en bloc resection while preserving quality of life.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
半生瓜发布了新的文献求助10
刚刚
刚刚
刚刚
世界发布了新的文献求助10
刚刚
RR完成签到 ,获得积分10
1秒前
1秒前
1秒前
hahaxiao完成签到,获得积分10
1秒前
Arjun发布了新的文献求助10
1秒前
闷闷发布了新的文献求助10
2秒前
3秒前
小玲发布了新的文献求助10
4秒前
4秒前
大力发布了新的文献求助10
4秒前
wang发布了新的文献求助10
5秒前
科目三应助Hedy采纳,获得10
5秒前
5秒前
6秒前
慕青应助平淡的苡采纳,获得10
6秒前
哈利哈瑞完成签到,获得积分10
6秒前
煎饼狗子发布了新的文献求助10
6秒前
6秒前
6秒前
ding应助David采纳,获得10
6秒前
小马甲应助半生瓜采纳,获得10
6秒前
6秒前
8秒前
yh完成签到,获得积分10
8秒前
2344发布了新的文献求助10
8秒前
8秒前
9秒前
专一的幻莲完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
桐桐应助qiany采纳,获得10
10秒前
大聪明应助Tao采纳,获得10
10秒前
理你完成签到,获得积分10
10秒前
10秒前
笑笑发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7334551
求助须知:如何正确求助?哪些是违规求助? 8948826
关于积分的说明 18987193
捐赠科研通 6988457
什么是DOI,文献DOI怎么找? 3217459
关于科研通互助平台的介绍 2383739
邀请新用户注册赠送积分活动 2197528